Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 11, 2016 07:01 ET | Source: Emergent Biosolutions, Inc.

Emergent Biosolutions Announces Preliminary 2015 Financial Results, Provides 2016 Financial Outlook, and Outlines New Five-Year (2016-2020) Strategic Growth Plan

2015 Preliminary Estimates:Total revenues of $520 to $525 million, a 16% increase over 2014 (at midpoint)GAAP net income of $60 to $64 million, a 69% increase over 2014 (at midpoint)Adjusted net...
January 10, 2016 12:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Receives Favorable IRS Private Letter Ruling in Connection With its Planned Biosciences Business Spin-Off

GAITHERSBURG, Md., Jan. 10, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has received a favorable private letter ruling from the Internal Revenue Service...
December 22, 2015 16:01 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Announces Composition of Board of Directors of New Spin-Off Company Aptevo Therapeutics

GAITHERSBURG, Md., Dec. 22, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the anticipated composition of the board of directors of Aptevo Therapeutics Inc., which...
December 21, 2015 16:15 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Participate in First Quarter 2016 Investor Conferences

GAITHERSBURG, Md., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will participate in the following...
November 24, 2015 16:01 ET | Source: Emergent Biosolutions, Inc.

FDA Approves Emergent BioSolutions' BioThrax for Post-Exposure Prophylaxis

GAITHERSBURG, Md., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that the U.S. Food and Drug Administration (FDA) approved its supplemental Biologics...
November 05, 2015 16:15 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Reports Third Quarter and Nine Months 2015 Financial Results

GAITHERSBURG, Md., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and nine months ended September 30, 2015. FINANCIAL...
October 22, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions to Release Third Quarter 2015 Financial Results and Conduct a Conference Call on November 5, 2015

GAITHERSBURG, Md., Oct. 22, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, November 5, 2015 at 5:00 pm (Eastern Time) to discuss the...
August 13, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Receives $44 Million CDC Contract to Further Advance Vaccinia Immune Globulin Intravenous Program

GAITHERSBURG, Md., Aug. 13, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that the Centers for Disease Control and Prevention (CDC) has exercised options under...
August 06, 2015 07:01 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Announces Plan to Implement Tax-Free Spin-Off of Biosciences Business Into a Separate Publicly-Traded Company

GAITHERSBURG, Md., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that its Board of Directors has authorized management to pursue a tax-free spin-off of the...
August 06, 2015 07:00 ET | Source: Emergent Biosolutions, Inc.

Emergent BioSolutions Reports Second Quarter and Six Months 2015 Financial Results and Reaffirms 2015 Guidance

GAITHERSBURG, Md., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and six months ended June 30, 2015. Financial highlights...